Description

Novoparin solution for injections 80 mg. syringe 0.8 ml. №2

Ingredients

Novoparin contains 80 mg of the active ingredient per 0.8 ml syringe.

Dosage

The recommended dosage of Novoparin solution for injections is determined by a healthcare provider based on the individual’s condition and needs.

Indications

Novoparin is indicated for the prevention and treatment of blood clots in conditions such as deep vein thrombosis and pulmonary embolism.

Contraindications

Do not use Novoparin if you have a history of heparin-induced thrombocytopenia or hypersensitivity to any of the components in the product.

Directions

Novoparin is administered by injection under the skin. Follow the instructions provided by your healthcare provider for the correct administration technique.

Scientific Evidence

Studies have shown that Novoparin is effective in preventing and treating blood clots with a favorable safety profile.

Additional Information

It is important to monitor for signs of bleeding while using Novoparin and to report any unusual symptoms to your healthcare provider promptly.

Pharmacological Effects: Novoparin works by inhibiting the activity of certain clotting factors in the blood, thereby preventing the formation of blood clots. This mechanism of action helps reduce the risk of thrombotic events.

Clinical Trials: Clinical trials have demonstrated the efficacy of Novoparin in various patient populations, showing its effectiveness in both prevention and treatment of thrombotic disorders. One study published in the Journal of Thrombosis and Haemostasis reported a significant reduction in the incidence of recurrent venous thromboembolism in patients treated with Novoparin compared to placebo.